SSG’s Clinical Reach comprises of a network in Asia that spans over 14 depots in key cities. SSG provides integrated end-to-end supply chain services and specializes in storage and distribution of Investigational Drugs used in Phase I through Phase IV open labeled, blinded or randomized clinical studies.
Our Clinical Reach management team plan and implement studies using state-of-the-art proprietary IT systems and SSG’s depot network infrastructure. Hence, enabling us to develop customized depot solutions that address protocol specific key concerns in areas of drug availability, risk, quality, safety, time, cost and drug disposal. SSG’s regional distribution center’s SOPs and systems are GCP compliant as well as ISO 9001:2000, GMP and GSDP certified.
We provide clients with a single contact point Asia to ensure consistency within a culturally and linguistic diverse region. Combining experience, expertise and commitment with Zuellig Pharma’s stringent quality guidelines, the result is consistent high quality and compliance throughout Asia.
For more information, please click here.